Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)
Clinical trial NCT04978597 · COMPLETED
Trial details
- NCT number
- NCT04978597
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-31
- Primary completion
- 2023-01-11
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.